Adrenocorticoid Steroids Flashcards

1
Q

Physio GCs

A

Immune and metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Physio MCs

A

Blood presseure (salt stuff)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmaco use of GCs

A

Inflam and autoimmune dzs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharma use of MCs

A

Hypertension and heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Glucocorticoid metabolic effects

A

Increase gluconeogenesis
Decrease glucose uptake in muscles and fat
Increase fat breakdown

Net effect is increase in plasma glucose…can worsen glucose control in diabetic patients

PEPCK enzyme is important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Glucocorticoids and stress

A

Provides body with increased energy via increased glucose levels…causes increased in blood pressure by activating vasoconstrictor stimuli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GC and blood cell levels

A

Decrease eosinophils, basophils, monocytes, and lymphocytes
Increases Hemoglobin, erythrocytes, platelets, and PMNs

Decrease in Th17s

Both innate nad immune response decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most important therapeutic property of GCs

A

Anti-inflam

Decrease synthesis of pro inflam cytokines and increase synthesis of anti-inflam cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bad effects of GCs

A

Exacerbation of ulcers via gastric acid and pepsin production
Altered mental status
Exaerbate bone loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GC mechanism of action at nuclear level

A

Interact with GR…moves to nucleus to increase anti-inflam genes, decrease expression of pro-inflam, interfere with NF-kB to decrease pro-inflam cytokines

Takes a while

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GC other mech of action

A

Decreases expression of COX 2 which decreases prostanoid expression

Also inccreases Annexin 1 when inhibits phospholipase A2 and is also agonist of lipoxin receptor than inhibits inflam response

Decreased AA and decreased prostanoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cortisol affinity

A

Same for Anti-inflam effect and salt effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prednisone as a prodrug

A

Converted to prednisolone…metabolized by CYP3A4…good for tapering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Uses of GCs

A
Replacement therapy 
Acute inflammation 
Neoplastic dz 
Autoimmune dz 
Chornic inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adverse effects of GCs

A
Decreased growth in children
Osteoporosis 
Glaucoma 
Increased infection risk 
Centripetal distr of body fat 
Hirsutism 
Increased appetite 
Hypertension
Emotional
Peripheral edema
Peptic ulcer
Hypokalemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When to withdraw GCs

A

When max benefit obtained
When indequate benefit obtained after adequate trial
Side effects

17
Q

Immediate cessation of GCs

A

Seroid induced acute psychosis unresponse to antipsychotics

Herpes viral corneal infections

18
Q

Typical withdrawl of GCs

A

If tx up to 10mg/day, then reduce by 2.5 mg until 5mg/day, after that, reduce by 1 mg/day

19
Q

Asthma pathology

A

Bronchial smooth muscle contracts
Bronchial walls inflamed
Mucus secretions are high

20
Q

GCs to treat asthma

A

Inhaled is first choice, but can more to oral if there if severe

No others are as effective as inhaled GCs to control long term asthma

21
Q

Benefits of GCs to tx asthma

A

Reduced bronchial hyper-responsiveness, prevention of late asthmatic response, and enhanced lung funciton

22
Q

Inhaled GCs to prevent asthma and advantage

A

Budesonide

Minimal side effects 
Low oral bioavailabiltiy 
Delivered directly to airways 
Fraction of dose used systemically
Small amount absorbed 

Undergoes first pass effect

23
Q

GC adverse effects in the asthmatic patient

A

Growth retardation…less severe side effects overall than oral

Dysphonia (hoarse voice)

Topical candidiasis (use larger spacer and rinse to prevent)

24
Q

GCs to treat autoimmunes

A

Achieve lowest possible disease activity is the goal…improve the quality of life, don’t cure

25
Q

SLE and how GCs used

A

Lupus
Basically body creates antibodies to itself due tp apoptotic and necrotic cells

Low dose GCs can be used to treat most…GCs should be used mostly just for acute or subacute control of symptoms

26
Q

Tx of cutaneous lupus

A

Topical glucocorticoids or intralesional injecion of triamcinalone

27
Q

Treatment of mild SLE

A

Induction therapy of prednisone for 4-6 weeks and then tapered to lower dose for maintenance therapy

28
Q

Treatment of severe acute flares of SLE

A

Pulse high dose for 3 days…few side effects

29
Q

Side effects associated with prednisone cutoff

A

7.5 mg/day

30
Q

Low doses of prednisone

A

Few adverse effects

31
Q

most rheumatologists avoid doses above

A

30 mg

32
Q

Glucocorticoid induced osteoporosis

A

Bone resorption increased, formation decreased, decreased calcium absorption from vit D interruptio

Also muscle atrophy leads to increased risk of fall

33
Q

Prevention of glucocorticoid induced osteoporosis

A

Lowest possible dose
Consider alternate route and schedule of administration (every other day, etc.)
Ensure sufficient intake of calcium, protein, and Vit D
Increase weight bearing exercise
Risk of falls

34
Q

Tx for glucocoritcoid induced osteoporosis

A

Ca intake
Vit D intake
Bisphosphonates

35
Q

MCs mechanism

A

Bind to MR receptor and upregulated the ENaC genes (sodium channel)

36
Q

Use of MCs

A

Use of agonist - fludrocortisone
Replacement therapy

Used instead of aldosterone bc aldosterone has very low bioavailability

37
Q

Metyrapone

A

Inhibits CYP11B1…treats patients with hypercortisolism from adrenal neoplasms or ACTH producing tumors

38
Q

Aminoglutethimide

A

Inhibits CYP11A and rate limiting biosynthetic step

Treats Cushings syndrome

Affects both Aldosterone and cortisol production

39
Q

Ketoconazole

A

inhibits CYP17

Most effective inhibitor for Cushing’s dz